Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenytoin Augmentation for SSRI Failures
NCT00146237Phase 4Completed
- Sponsor
- Be'er Sheva Mental Health Center
- Start
- Nov 2003
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of phenytoin in major depressive disorder (MDD), sponsored by Be'er Sheva Mental Health Center. Started Nov 2003; status: completed.
02
Drugs
phenytoin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00146237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146237.